GUIDELINES FOR SUPPORT OF SCIENTIFIC MEETINGS BY NIH - ADDITIONAL INFORMATION 
FOR NIDA CONFERENCE GRANTS

Release Date:  May 1, 2000

NOTICE:  DA-00-007

National Institute on Drug Abuse

This Notice provides additional information related to NIDA support of 
conference grants, as announced in the NIH Guide of October 30, 1998, 
available at 
http://grants.nih.gov/grants/guide/notice-files/not98-151.html.

NIDA is interested in supporting investigator initiated scientific 
meetings that will advance the mission of the Institute.  NIH defines a 
scientific meeting as a “gathering, symposium, seminar, workshop, or 
other organized, formal conference where persons assemble to coordinate, 
exchange and disseminate information or to explore or clarify a defined 
subject, problem or area of knowledge.”  NIDA wishes to elaborate on 
this definition and clarify the types of scientific meetings for which 
it will consider applications under the R13 mechanism. NIDA will support 
small meetings in their entirety and will contribute support toward 
large conferences that have other support. In both cases, the NIDA 
supported portion of the meeting should primarily focus on advancing the 
research development mission of the Institute.  Meetings should advance 
the research agenda by fostering creativity and innovation and not 
solely by providing training in specific techniques, methods, or 
technologies.  Insofar as the agenda, format, and facilities will allow, 
meetings should maximize the number of participants and be inclusive of 
a large number of participants with varied scientific backgrounds and 
demographic characteristics.  They should foster interactions and 
exchange among persons who would otherwise be unlikely to engage in such 
interactions and exchanges.  Participation should not be restricted to 
persons who already regularly associate or communicate through other 
NIDA sponsored events, conferences, associations, or other means. The 
inclusion of junior investigators and post-doctoral fellows is 
encouraged.  In the case of meetings proposed to advance international 
collaboration, it should be clear how such collaboration will advance 
U.S. interests.  

NIDA-supported meetings should result in a specific product or 
measurable intermediate outcome that allows evaluation of a meeting’s 
effectiveness in fostering the final outcome of advancing NIDA-relevant 
research. Such products might include published papers or monographs, 
reports or data made available through the Internet, evaluation data on 
participation and interactions fostered through the meeting, or 
examinations of specific outcomes.  

NIDA will support such meetings with up to $25,000 per year. The 
Principal Investigator, with co-signature of the applicant 
organization’s designated official, must submit a letter of request and 
receive advance permission from NIDA in order to submit. Send such 
requests to the NIDA contact named below.  

Applicants may request funding for multiple years.  Because of the 
difficulty in planning an agenda, topics, and speakers in subsequent 
years, NIDA encourages multiple year applications only when the 
applicant organization has a well established history of conducting 
meetings and can document the organizational ability to anticipate and 
respond to emerging needs, or when the application can provide specific 
details on the agenda, topics, and speakers for ensuing years.  In the 
latter case, the application should also provide a rationale for 
anticipating that the needs will not change.

In addition to the standard NIH criteria for conference grants, applications 
will be evaluated on the basis of the meeting’s likelihood of advancing a 
research agenda and the quality of the plans for providing and evaluating 
specific products and outcomes. 

INQUIRIES 

Inquiries are encouraged. The opportunity to clarify any issues or answer 
questions from potential applicants is welcome. In addition, any applicant 
requesting more than $25,000 in a single year of support must secure approval 
to submit and be considered. 

For further information, contact: 

Teresa Levitin, Ph.D.
Office of Extramural Affairs
National Institute on Drug Abuse
6001 Executive Boulevard, Room 3158, MSC 9547
Bethesda, MD 20892-9547
Telephone: (301) 443-2755
FAX:  (301) 443-0538
Email: tlevitin@nida.nih.gov


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.